ZINA GOLDVEKHT: Open Payments
NPI 1164480844 · FOREST HILLS, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,054 in 92 payments from 20 companies in 2025. Trend: 2023 $2,008 · 2024 $2,011 · 2025 $2,054
Food & beverage: $2,054
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 16 | $329 |
| GENZYME CORPORATION | 6 | $205 |
| ABBVIE INC. | 4 | $204 |
| Arcutis Biotherapeutics, Inc. | 13 | $192 |
| Janssen Biotech, Inc. | 9 | $147 |
| Amgen Inc. | 6 | $143 |
| Organon LLC | 10 | $142 |
| PFIZER INC. | 5 | $118 |
| Lilly USA, LLC | 3 | $85 |
| UCB, Inc. | 3 | $80 |
Products named: OPZELURA, DUPIXENT, SKYRIZI, Zoryve, TREMFYA, OTEZLA, CIBINQO, Bimzelx.
Industry payments across NY — which companies pay providers there.
